Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing
Amount Raised
$33.1 Million
Round Type
Series B
BrightonBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
Enterprise Therapeutics Ltd announced the closing of a £26 million Series B follow-on financing round led by Panakes Partners, with participation from existing investors Versant Ventures, Novartis Venture Fund, Forbion, Epidarex Capital, and IP Group. The investment will fund the Phase 2a clinical trial of the Company’s lead programme, ETD001, to deliver clinical proof of concept to treat cystic fibrosis, and enable the expansion of the Company’s clinical activities into Italy via addition of clinical investigator sites and progression of its other preclinical programmes targeting mucus congestion.
Quick answer
Enterprise Therapeutics Ltd raised $33.1 Million in a Series B round, dated January 30, 2024. Investors: IP Group, Epidarex Capital, Forbion, Novartis Venture Fund, Versant Ventures and Panakes Partners. Enterprise Therapeutics Ltd is based in Brighton, England, United Kingdom.
- How much did Enterprise Therapeutics Ltd raise?
- Enterprise Therapeutics Ltd raised $33.1 Million in a Series B round on January 30, 2024.
- Who invested in Enterprise Therapeutics Ltd?
- IP Group, Epidarex Capital, Forbion, Novartis Venture Fund, Versant Ventures and Panakes Partners are named as investors in this round.
- What does Enterprise Therapeutics Ltd do?
- Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.
- Where is Enterprise Therapeutics Ltd based and how big is it?
- Enterprise Therapeutics Ltd is based in Brighton, England, United Kingdom.
- Who are the decision-makers at Enterprise Therapeutics Ltd?
- Fundz holds 1 contact at Enterprise Therapeutics Ltd. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Enterprise Therapeutics Ltd that raised within 45 days of this round, from Fundz verified event records.
- Adipo Therapeutics raised $1.9M (Seed) on March 7, 2024.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- Denali Therapeutics raised $500M on February 29, 2024.
- vTv Therapeutics Inc. raised $51M on February 27, 2024.
- IsomAb raised $7.5M (Funding Round) on February 20, 2024.
Who to call at Enterprise Therapeutics Ltd, and when
A new round usually means Enterprise Therapeutics Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Enterprise Therapeutics Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enterprise Therapeutics Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enterprise Therapeutics Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enterprise Therapeutics Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEnterprise Therapeutics Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.